203 related articles for article (PubMed ID: 19368735)
1. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
Soylu A; Ince AT; Polat H; Yasar N; Ciltas A; Ozkara S; Tasci AI
Ann Clin Microbiol Antimicrob; 2009 Apr; 8():12. PubMed ID: 19368735
[TBL] [Abstract][Full Text] [Related]
2. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration.
Graziano DA; Jacobs D; Lozano RG; Buck RL
J Urol; 1991 Oct; 146(4):1118-9. PubMed ID: 1895437
[TBL] [Abstract][Full Text] [Related]
3. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
[TBL] [Abstract][Full Text] [Related]
4. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.
Ozbakkaloglu B; Tünger O; Sürücüoglu S; Lekili M; Kandiloglu AR
Int Urol Nephrol; 1999; 31(1):49-53. PubMed ID: 10408303
[TBL] [Abstract][Full Text] [Related]
5. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
Marans HY; Bekirov HM
J Urol; 1987 Jan; 137(1):111-2. PubMed ID: 3795348
[TBL] [Abstract][Full Text] [Related]
6. [Granulomatous hepatitis due to Mycobacterium complex following Bacillus Calmette-Guérin intravesical instillation].
Villamil-Cajoto I; Jove MJ; Serrano M; Pousa M
Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):759-61; author reply 761-2.. PubMed ID: 20826041
[No Abstract] [Full Text] [Related]
7. Granulomatous hepatitis as a complication of intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma.
Arzt MR; Forouhar F
Ann Clin Lab Sci; 1995; 25(5):409-13. PubMed ID: 7486816
[TBL] [Abstract][Full Text] [Related]
8. Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.
Lestre SI; Gameiro CD; João A; Lopes MJ
An Bras Dermatol; 2011; 86(4):759-62. PubMed ID: 21987145
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
Leebeek FW; Ouwendijk RJ; Kolk AH; Dees A; Meek JC; Nienhuis JE; Dingemans-Dumas AM
Gut; 1996 Apr; 38(4):616-8. PubMed ID: 8707098
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
Molina JM; Rabian C; D'Agay MF; Modai J
J Urol; 1992 Mar; 147(3):695-7. PubMed ID: 1538462
[TBL] [Abstract][Full Text] [Related]
11. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
[TBL] [Abstract][Full Text] [Related]
12. Granulomatous hepatitis and hemophagocytic syndrome after bacillus Calmette-Guerin bladder instillation.
Thevenot T; Di Martino V; Lagrange A; Petrella T; Faucher JF; Fontan J; Terebus M; Miguet JP; Bresson-Hadni S
Gastroenterol Clin Biol; 2006 Mar; 30(3):480-2. PubMed ID: 16633319
[TBL] [Abstract][Full Text] [Related]
13. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
Harding GE; Lawlor DK
J Vasc Surg; 2007 Jul; 46(1):131-4. PubMed ID: 17606130
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Bacillus Calmette-Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review.
Shimizu G; Amano R; Nakamura I; Wada A; Kitagawa M; Toru S
BMC Infect Dis; 2020 Sep; 20(1):708. PubMed ID: 32993546
[TBL] [Abstract][Full Text] [Related]
15. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
Linn R; Klimberg IW; Wajsman Z
J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508
[TBL] [Abstract][Full Text] [Related]
16. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.
Deresiewicz RL; Stone RM; Aster JC
J Urol; 1990 Dec; 144(6):1331-3; discussion 1333-4. PubMed ID: 2231918
[TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
[TBL] [Abstract][Full Text] [Related]
18. Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer.
Niwa N; Kikuchi E; Matsumoto K; Kosaka T; Mizuno R; Oya M
J Urol; 2018 Jun; 199(6):1446-1451. PubMed ID: 29307686
[TBL] [Abstract][Full Text] [Related]
19. Vascular and other serious infections with Mycobacterium bovis after bacillus of Calmette-Guérin therapy for bladder cancer.
Hellinger WC; Oldenburg WA; Alvarez S
South Med J; 1995 Dec; 88(12):1212-6. PubMed ID: 7502112
[TBL] [Abstract][Full Text] [Related]
20. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
Ersoy O; Aran R; Aydinli M; Yonem O; Harmanci O; Akdogan B; Pinar A; Sokmensuer C; Bayraktar Y
Indian J Gastroenterol; 2006; 25(5):258-9. PubMed ID: 17090848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
